JW Lifescience Corporation (KRX:234080)
South Korea
· Delayed Price · Currency is KRW 11,400
-100 (-0.87%)
At close: Mar 25, 2025, 3:30 PM KST
JW Lifescience Revenue
In the year 2024, JW Lifescience had annual revenue of 222.48B KRW with 7.55% growth. JW Lifescience had revenue of 54.79B in the quarter ending December 31, 2024, with 2.16% growth.
Revenue
222.48B
Revenue Growth
+7.55%
P/S Ratio
0.78
Revenue / Employee
739.13M
Employees
301
Market Cap
173.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 222.48B | 15.62B | 7.55% |
| Dec 31, 2023 | 206.86B | 17.93B | 9.49% |
| Dec 31, 2022 | 188.93B | 19.11B | 11.26% |
| Dec 31, 2021 | 169.82B | -13.70B | -7.47% |
| Dec 31, 2020 | 183.52B | 13.30B | 7.81% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition